Cavan P. Bailey

Statistics

Publications

Citations

204

H-Index

Active since

2013

Affiliations

The University of Texas Health Science Center at Houston(Current)

The University of Texas MD Anderson Cancer Center

Sidney Kimmel Cancer Center

Nationwide Children's Hospital

Thomas Jefferson University

Cavan P. Bailey is an author at The University of Texas Health Science Center at Houston specializing in cancer immunotherapy, oncology, and medicine.

ORCID

Publications per year

2013–2021

Publications

Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma

Cavan P. Bailey, Mary Figueroa, Achintyan Gangadharan et al. · Neuro-Oncology · 2020 · 61 citations · Full text

Medicine, Cancer Biology, Pharmacology +16

Induction of cell death by the novel proteasome inhibitor marizomib in glioblastoma in vitro and in vivo

Christa A. Manton, Blake Johnson, Melissa Singh et al. · Scientific Reports · 2016 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17

Scaffolding LSD1 Inhibitors Impair NK Cell Metabolism and Cytotoxic Function Through Depletion of Glutathione

Cavan P. Bailey, Mary Figueroa, Achintyan Gangadharan et al. · Frontiers in Immunology · 2020 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity

Cavan P. Bailey, Tülin Budak-Alpdoǧan, Christopher Tor Sauter et al. · Oncotarget · 2017 · 23 citations · Full text

Life Sciences, Immunology, Oncology +17

Computational immune infiltration analysis of pediatric high‐grade gliomas (pHGGs) reveals differences in immunosuppression and prognosis by tumor location

Cavan P. Bailey, Ruiping Wang, Mary Figueroa et al. · Computational and Systems Oncology · 2021 · 16 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 6